10x Genomics announced PharosAI will use its Xenium spatial platform to generate multimodal cancer datasets from decades of archived NHS patient samples. The £18.9 million government-supported initiative brings together King's College London, Queen Mary University of London and several NHS trusts to link genomic, transcriptomic, imaging and spatial biology data with custom AI models through 2027. PharosAI said it will make datasets broadly available to researchers to accelerate diagnostic advances and drug discovery. Anita Grigoriadis, CEO of PharosAI, argued that fragmented data has slowed AI progress in cancer and that integrated, high-quality spatial datasets are a necessary foundation for next-generation tools.